D-C Fischer - JoVE Visualize

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

The Journal of Clinical Endocrinology and Metabolism|October 14, 2011

Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportionM Živičnjak, D Schnabel, H Staude, et al.

Gynecologic Oncology|December 6, 2001

Adenovirus-mediated thymidine kinase gene therapy in combination with topotecan for patients with recurrent ovarian cancer: 2.5-year follow-upA Hasenburg, X W Tong, D C Fischer, et al.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 28, 2002

Histologic and immunohistochemical analysis of tissue response to adenovirus-mediated herpes simplex thymidine kinase gene therapy of ovarian cancerA Hasenburg, D C Fischer, X-W Tong, et al.

Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

The Journal of Clinical Endocrinology and Metabolism|October 14, 2011

Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportionM Živičnjak, D Schnabel, H Staude, et al.

Gynecologic Oncology|December 6, 2001

Adenovirus-mediated thymidine kinase gene therapy in combination with topotecan for patients with recurrent ovarian cancer: 2.5-year follow-upA Hasenburg, X W Tong, D C Fischer, et al.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 28, 2002

Histologic and immunohistochemical analysis of tissue response to adenovirus-mediated herpes simplex thymidine kinase gene therapy of ovarian cancerA Hasenburg, D C Fischer, X-W Tong, et al.

Pageof 5